editor@ajptr.com
9409046853
e-ISSN: 2249-3387
logo

American Journal of PharmTech Research

Published

Docking of Hematoporphyrin on various Anticancer Drugs targeting enzymes

Published in June 2016 Issue 3 (Vol. 6, Issue 3, 2016)

Docking of Hematoporphyrin on various Anticancer Drugs targeting enzymes - Issue cover

Abstract

The present study deals with docking of Hematoporphrin with various anticancer drugs targeting enzymes. The targets used were PDB-ID 2Y3I, PDB-ID 3OZZ, PDB-ID 3UEN and PDB-ID 4O33. Hematoporphyrin docked with these enzymes and interactions between the enzyme and compound were measured and compared with standard Paclitaxel. The study concluded that, the compound (Hematoporphyrin) isolated from plant were high interactions with PDB-ID 4O33 when compared to standard.

Authors (3)

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Article Information

AJPTR63013

AJPTR-01-001019

2016-06-01

Article Impact

Views:2,675
Downloads:754

How to Cite

Sundaresan & Ramalingam & Rajendren (2016). Docking of Hematoporphyrin on various Anticancer Drugs targeting enzymes. American Journal of PharmTech Research, 6(3), xx-xx. https://ajptr.com/articles/AJPTR63013

Article Actions

Whatsapp